S Strong 1,2 , NS Blencowe 1,2 ,T Fox 1 , C Reid 3 , T Crosby 4 , H.Ford 5 , J M Blazeby 1,2 1 School of Social and Community Medicine, Canynge Hall, University of Bristol, Bristol UK. 2 Division of Surgery, Head & Neck, University Hospitals Bristol NHS Foundation Trust, Bristol, UK. 3 Division of Specialised Services, University Hospitals Bristol NHS Foundation Trust, Bristol, UK. 4 Velindre NHS Trust, Unit 2 Charnwood Court, Nantgarw, Cardiff 5 Addenbrooke’s Department of Oncology & Cambridge Cancer Trials Centre, Cambridge e role of multi-disciplinary teams in decisi ng for patients with recurrent malignant dis
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
S Strong 1,2, NS Blencowe1,2,T Fox1, C Reid3 , T Crosby4, H.Ford5, J M Blazeby1,2
1School of Social and Community Medicine, Canynge Hall, University of Bristol, Bristol UK.
2Division of Surgery, Head & Neck, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
3Division of Specialised Services, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
4Velindre NHS Trust, Unit 2 Charnwood Court, Nantgarw, Cardiff
5Addenbrooke’s Department of Oncology & Cambridge Cancer Trials Centre, Cambridge
The role of multi-disciplinary teams in decision making for patients with recurrent malignant disease
MDT meetings
• Picture of mdt team
UGI cancer survival
1. Allum et al. Journal of Clinical Oncology. 2009
Aims1. investigate role MDT in decision-making
for patients with disease recurrence
2. Consider how issues addressed nationally
Methods• Sequential MDT records screened
• Patients with possible recurrence identified
• Notes reviewed and info recorded about:symptomsreason for referral & sourcetreatment decision & implementation